HIV-1, reactive oxygen species, and vascular complications

We summarize the clinical and experimental evidence demonstrating HIV- and HIV antiretroviral therapy-induced alterations in reactive oxygen species and how these effects likely contribute to vascular dysfunction and disease

Kristi M. Porter; Roy L. Sutliff


Scholarcy highlights

Need more features? Save interactive summary cards to your Scholarcy Library.